Crossmark

Development and validation of a UPLC-MS/MS method for the quantification of parsaclisib and its application to pharmacokinetics and metabolic stability studies

Crossref DOI link: https://doi.org/10.1186/s13065-025-01569-0

Published Online: 2025-07-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Chenjian

Wang, Peiqi

Chen, Jie

Wu, Hualu

Yu, Yige
License Information

Text and Data Mining valid from 2025-07-03

Version of Record valid from 2025-07-03
More Information

Article History

Received: 25 April 2025

Accepted: 23 June 2025

First Online: 3 July 2025

Declarations

:

: All animal procedures and experimental protocols were approved by the Laboratory Animal Ethics Committee of The First Affiliated Hospital of Wenzhou Medical University (Ethics approval number: WYYY-IACUC-AEC-2023-044).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below